Fundz

Claritev

McLean, Virginia, United States · Analytics, Health Care, hospital & health care

Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-cla

Key facts

Headquarters
McLean, Virginia, United States
Employees
2,700
Industries
Analytics, Health Care, hospital & health care
Status
Public (CTEV)
Website
claritev.com
LinkedIn
Company page

Recent activity at Claritev

  • : SEC 8-K (5.02): On October 15, 2026, Claritev Corporation increased the size of its Board from eleven to twelve directors by appointing Ms. Jennifer Main to fill the newly created position as a Class II director and member of the Audit Committee. Concurrently, Mr. Jason Kap stepped down from the Audit Committee. Ms. Main's appointment follows the recommendation of the Nominating and Corporate Governance Committee and is crucial for enhancing the Board's oversight capabilities. She will be compensated as per the Company's non-employee director compensation policy, which was previously detailed in the proxy statement filed on March 20, 2026.
  • : SEC 8-K (5.02): On September 14, 2026, Claritev Corporation's Board of Directors appointed Mr. Ben Letham as a Class I director, filling the vacancy left by the passing of Mr. John Prince. This appointment is effective immediately and includes Mr. Letham's placement on the Board's Risk Committee. Mr. Letham has no familial ties to current directors or executive officers and does not have any significant financial interest in required disclosures. His compensation will align with the established non-employee director compensation policy of the Company, which emphasizes fair remuneration for board services.
  • : SEC 8-K (8.01): On July 6, 2026, Claritev Corporation reported the passing of Mr. John Prince, a member of its Board of Directors since June 2023, and a participant in the Audit Committee at the time of his death. His contributions to the company were significant, and his absence will be felt deeply within the organization. The report indicates a transition in the Board's structure and potentially impacts the company's governance as they may need to appoint a new director to fill the vacancy. This event underlines the dynamic nature of the company's leadership as they navigate changes in management and governance.
  • : SEC 8-K (8.01): On July 6, 2026, Claritev Corporation reported the death of Mr. John Prince, a member of its Board of Directors since June 2023 and part of the Audit Committee. This event denotes a change in the company's governance, as Mr. Prince's contributions to the board will be missed. His recent involvement and roles indicate that his passing could have implications for board dynamics and committee functions moving forward.
  • : SEC 8-K (7.01):
  • : SEC 8-K (7.01):
  • : SEC 8-K (5.02): On April 29, 2026, Claritev Corporation's stockholders approved an amendment to the 2020 Omnibus Incentive Plan, increasing the number of shares reserved for issuance by 2,375,000 shares. This amendment was one of several proposals voted on during the Company’s 2026 Annual Meeting of Stockholders, which included the election of four Class III directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and an advisory vote on executive compensation. The amendment to the plan is significant as it allows for additional equity awards that may affect company performance and employee compensation strategies. The approval outcomes were favorable for all proposals presented at the meeting.
  • : SEC 8-K (7.01): On March 16, 2026, Claritev Corporation hosted its 2026 Investor Day in New York. During this event, the management team presented vital information to stakeholders, aligned with Regulation FD compliance, ensuring that all investors received equal access to the Company's important disclosures. The slide presentation used in the Investor Day is provided as Exhibit 99.1, and while the information is being furnished, it is not considered 'filed' under the provisions of the Exchange Act, thereby limiting its legal implications. This event is strategically significant as it emphasizes Claritev's commitment to transparency with investors and stakeholders regarding its future direction and performance.
  • : SEC 8-K (7.01): On March 16, 2026, Claritev Corporation hosted its 2026 Investor Day in New York, with the management team presenting key updates and strategic plans to investors. The event provided an opportunity for direct engagement with stakeholders, underlining the company's commitment to transparency and information dissemination. The company has furnished the details of this event in its filing as part of Regulation FD compliance. The attached presentation (Exhibit 99.1) likely includes important insights into the firm's future direction and operational highlights, impacting investor perceptions and stock performance.
  • : SEC 8-K (7.01): On January 15, 2026, Claritev Corporation announced that it will be making a slide presentation available on its website for investors. This presentation is part of the Company’s efforts to comply with Regulation FD, which aims to ensure that all investors have equal access to material information. The slide presentation, attached as Exhibit 99.1, contains important updates and forward-looking information that may impact investors' decisions. Importantly, the information will not be considered 'filed' under the Securities Exchange Act and has specific legal disclaimers regarding its incorporation into future filings.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Leadership

  • Brock Albinson, Chief Accounting Officer
  • Jigar S. Patel, Chief Medical Officer
  • Fernando Schwartz, Chief Artificial Intelligence Officer
  • Doug Garis, Vice President
  • Travis Dalton, President

Verified email and direct lines for Claritev’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Claritev in the news

Companies similar to Claritev

About Claritev: questions and answers

What does Claritev do?

Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-cla

Where is Claritev headquartered?

Claritev is headquartered in McLean, Virginia, United States.

How many employees does Claritev have?

Claritev has about 2,700 employees.

Who leads Claritev?

Doug Garis is a Vice President at Claritev.

What is the latest news on Claritev?

On Oct 15, 2025, SEC 8-K (5.02): On October 15, 2026, Claritev Corporation increased the size of its Board from eleven to twelve directors by appointing Ms. Jennifer Main to fill the newly created position as a Class II director and member of the Audit Committee. Concurrently, Mr. Jason Kap stepped down from the Aud

Is Claritev a public company?

Yes. Claritev is publicly traded under the ticker CTEV.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Claritev across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.